相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease
Francesc Casellas et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn's disease
Chiara Villa et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index
Michael J. Steward et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Postoperative recurrent luminal Crohn's Disease: A systematic review
Peter De Cruz et al.
INFLAMMATORY BOWEL DISEASES (2012)
Implementing changes in clinical practice to improve the management of Crohn's disease
Remo Panaccione et al.
Journal of Crohns & Colitis (2012)
Comparison of Magnetic Resonance Enterography With Endoscopy, Histopathology, and Laboratory Evaluation in Pediatric Crohn Disease
Cary G. Sauer et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease
J. Panes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease
L. S. Kiss et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response
Geert R. D'Haens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial
Remo Panaccione et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2011)
Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging
Konstantinos Karmiris et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Assessment of Inflammatory and Fibrotic Stenoses in Patients with Crohn's Disease Using Contrast-Enhanced Ultrasound and Computerized Algorithm: A Pilot Study
Ramin Schirin-Sokhan et al.
DIGESTION (2011)
MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease
Emanuele Casciani et al.
EUROPEAN RADIOLOGY (2011)
Validating Crohn's Disease Activity Indices for Use in Assessing Postoperative Recurrence
T. D. Walters et al.
INFLAMMATORY BOWEL DISEASES (2011)
Incidence and Clinical Outcomes of Intersphincteric Abscesses Diagnosed by Anal Ultrasonography in Patients with Crohn's Disease
Chiara Vigano et al.
INFLAMMATORY BOWEL DISEASES (2011)
Which Magnetic Resonance Imaging Findings Accurately Evaluate Inflammation in Small Bowel Crohn's Disease? A Retrospective Comparison with Surgical Pathologic Analysis
Magaly Zappa et al.
INFLAMMATORY BOWEL DISEASES (2011)
Crohn's Disease Activity Index Does Not Correlate with Endoscopic Recurrence One Year After Ileocolonic Resection
Miguel Regueiro et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Magnetic Resonance Imaging for Evaluation of Crohn's Disease: Validation of Parameters of Severity and Quantitative Index of Activity
Jordi Rimola et al.
INFLAMMATORY BOWEL DISEASES (2011)
MRI in Patients With Inflammatory Bowel Disease
Michael S. Gee et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy
Anastasios Koulaouzidis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
Dario Sorrentino et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
C-Reactive Protein and Disease Activity in Children with Crohn's Disease
Samantha Tilakaratne et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
Lamia Kallel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Early Crohn disease: a proposed definition for use in disease-modification trials
Laurent Peyrin-Biroulet et al.
GUT (2010)
Magnetic Resonance Follow-through Imaging for Evaluation of Disease Activity in Ileal Crohn's Disease: An Observational, Retrospective Cohort Study
C. A. Parisinos et al.
INFLAMMATORY BOWEL DISEASES (2010)
Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2010)
Endoscopy and MR Enteroclysis: Equivalent Tools in Predicting Clinical Recurrence in Patients with Crohn's Disease After Ileocolic Resection
Stavroula Koilakou et al.
INFLAMMATORY BOWEL DISEASES (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Magnetic Resonance Enterography for Suspected Inflammatory Bowel Disease in a Pediatric Population
Karin Horsthuis et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
High-sensitivity C-reactive protein in paediatric inflammatory bowel disease
Marianne Sidoroff et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
CT enterography of Crohn's disease
Amy K. Hara et al.
ABDOMINAL IMAGING (2009)
Prospective Comparison of State-of-the-Art MR Enterography and CT Enterography in Small-Bowel Crohn's Disease
Hassan A. Siddiki et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
Diagnostic and Prognostic Significance of Serum C-Reactive Protein Levels in Patients Admitted to the Department of Medicine
Rom Keshet et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
C. A. Lamb et al.
BRITISH JOURNAL OF SURGERY (2009)
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus
A. Bourreille et al.
ENDOSCOPY (2009)
Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy
Laura Maria Minordi et al.
EUROPEAN RADIOLOGY (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
J. Rimola et al.
GUT (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Questions and Answers on the Role of Fecal Lactoferrin as a Biological Marker in Inflammatory Bowel Disease
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Crohn Disease of the Small Bowel: Comparison of CT Enterography, MR Enterography, and Small-Bowel Follow-Through as Diagnostic Techniques
Seung Soo Lee et al.
RADIOLOGY (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Laboratory evaluation of inflammatory bowel disease
Allison Wong et al.
CURRENT OPINION IN PEDIATRICS (2008)
Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease
M. Fraquelli et al.
DIGESTIVE AND LIVER DISEASE (2008)
Review of fecal biomarkers in inflammatory bowel disease
Andrew D. Sutherland et al.
DISEASES OF THE COLON & RECTUM (2008)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
M. Henriksen et al.
GUT (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: Meta-analysis of prospective studies
Karin Horsthuis et al.
RADIOLOGY (2008)
Use of the Crohn's disease activity index in clinical trials of biological agents
Hugh James Freeman
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease
Chantal L. Koelewijn et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease
Gabriele Masselli et al.
EUROPEAN RADIOLOGY (2008)
Correlation between levels of C-reactive protein and clinical activity in Crohn's disease
S. Karoui et al.
DIGESTIVE AND LIVER DISEASE (2007)
Evaluation of postsurgical recurrence in Crohn's disease:: a new indication for capsule endoscopy?
Vicente Pons Beltran et al.
GASTROINTESTINAL ENDOSCOPY (2007)
Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
Marie-Arrhelle Denis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease
Marco Scarpa et al.
DISEASES OF THE COLON & RECTUM (2007)
Mapping from disease-specific measures to utility: An analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility
Martin J. Buxton et al.
VALUE IN HEALTH (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease
Thomas R. Walker et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study
A. Bourreille et al.
GUT (2006)
C-reactive protein and monitoring the activity of Crohn's disease
Levent Filik et al.
ADVANCES IN THERAPY (2006)
A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Yann Consigny et al.
INFLAMMATORY BOWEL DISEASES (2006)
Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease
Patrick Chamouard et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Bowel magnetic resonance imaging of pediatric patients with oral mannitol - MRI compared to endoscopy and intestinal ultrasound
AS Borthne et al.
EUROPEAN RADIOLOGY (2006)
Diagnosis of small bowel Crohn's disease:: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis
JG Albert et al.
GUT (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Magnetic resonance imaging in Crohn's disease
F Pilleul et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Small intestine contrast ultrasonography - An alternative to radiology in the assessment of small bowel disease
N Pallotta et al.
INFLAMMATORY BOWEL DISEASES (2005)
Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence
WR Ryan et al.
AMERICAN JOURNAL OF SURGERY (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
C-reactive protein as a marker for inflammatory bowel disease
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2004)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
The inflammatory bowel disease questionnaire - A review of its national validation studies
AG Pallis et al.
INFLAMMATORY BOWEL DISEASES (2004)
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
G Van Assche et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
CT of prominent pericolic or perienteric vasculature in patients with Crohn's disease: Correlation with clinical disease activity and findings on barium studies
SS Lee et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
分享论文
